SUPPLY AGREEMENT Dated as of May 5, 2016 by and between DURATA THERAPEUTICS INTERNATIONAL B.V. and CORREVIO INTERNATIONAL Sárl SUPPLY AGREEMENTSupply Agreement • May 17th, 2016 • Cardiome Pharma Corp • Pharmaceutical preparations • New York
This Supply Agreement (this “Agreement”), dated as of May 5, 2016 (the “Effective Date”), is made by and between Correvio International Sárl, a Swiss corporation with offices at Rue des Alpes 21, Case postale 1674, 1201 Geneva, Switzerland (“Licensee”), and Durata Therapeutics International B.V., a company registered in the Netherlands with offices at Spaces Zuidas II, Barbara Strozzilaan 101, 1083 HN Amsterdam, the Netherlands (“Allergan”). Each of Licensee and Allergan is referred to herein individually as a “Party” and collectively as the “Parties.” Certain capitalized terms have the meanings provided in Article I below.
LICENSE AGREEMENT Dated as of May 5, 2016 by and between DURATA THERAPEUTICS INTERNATIONAL B.V. andLicense Agreement • May 17th, 2016 • Cardiome Pharma Corp • Pharmaceutical preparations • New York
This License Agreement (this “Agreement”), effective as of May 5, 2016 (the “Effective Date”), is made by and between Durata Therapeutics International B.V., a private limited company registered in the Netherlands with offices at Barbara Strozzilaan 101, Spaces Zuida, Amsterdam, the Netherlands (“Allergan”), and Correvio International Sárl, a Swiss corporation with offices at Rue des Alpes 21, Case postale 1674, 1201 Geneva, Switzerland (“Licensee”). Each of Allergan and Licensee is referred to herein individually as a “Party” and collectively as the “Parties.” Certain capitalized terms have the meanings provided in Article I below.
